Provided is a composition exhibiting cell-activating activity of human hepatocellular carcinoma-derived cell line (HepG2), which provides anti-obesity effects (diet effects). The oral composition contains charcoal, caffeine, and medium-chain fatty acid triglyceride, wherein the content of the medium-chain fatty acid triglyceride is 0.1-5.0 mass perent. Figure 1

You do not currently have access to this content.